Research Reports | Market Assessment
June 2021

Asthma – Access & Reimbursement – Detailed, Expanded Analysis (US)

Table of contents

  • Asthma - Access & Reimbursement - Detailed, Expanded Analysis (US)
    • Access and Reimbursement Asthma US June 2021
Shubhendu Ghosh, Ph.D.
Shubhendu Ghosh, Ph.D.

Shubhendu Ghosh, Ph.D., is a senior business insights analyst on the Immune and Inflammatory Disorders team at Clarivate. His focus is the asthma therapy market. Previously, Dr. Ghosh was an associate editor at Nature Structural & Molecular Biology and a copy editor at Nature Medicine. He was also a scientific and developmental editor at Nature Research Editing Service. He holds a Ph.D. in biomedical sciences from the University of Massachusetts Medical School, a B.Sc. in microbiology from Delhi University, and an M.Sc. in biotechnology from Madurai Kamaraj University.

Chris Lewis
Chris Lewis

Chris Lewis is a primary research manager at Clarivate. She is responsible for the coordination, content review, and content generation of U.S. Access & Reimbursement reports, including authoring select A&R reports on managed care trends. Before this position, Ms. Lewis was a senior analyst at HealthLeaders-InterStudy. She analyzed the managed care markets in California, New York, and Pennsylvania. She also launched and authored the Pharmacy Benefit Manager profile series. She received her bachelor’s degree from California State University in Sacramento.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports